Ingredient · Corpus exposure
D-Biotin regulatory exposure
RegSig tracks regulatory signals that intersect products containing d-biotin in the platform reference corpus—linking ingredient-level exposure to portfolio triage, time horizon, and recommended actions.
- 13 corpus products
- 2 representative signals
- 2 regulatory topics
13
Corpus products
2
Linked signals
2
Topics
Regulatory signals affecting D-Biotin
Cross-layer Update on Front-of-pack Claim Display Rules for Cross-jurisdiction Labels
Medium-termFront-of-Pack Labeling
What changed: FDA adopted front-of-pack claim display rules for claim-bearing retail packs in Global, updating what must be substantiated on pack and in supporting records.
Compliance Enforcement on Nutrition Labeling and Point-of-purchase Display for Label and Claims
Long-termNutrition Claims
What changed: FSIS adopted Nutrition Labeling and Point-of-Purchase Display Requirements for nutrition-labeled SKUs in Global, updating what must be substantiated on pack and in supporting records.
Related topics
Individual access
Monitor D-Biotin signals in your portfolio
RegSig maps global regulatory signals directly to your product portfolio. Independent practitioners can get started with usage-based billing—pay only for what you run.